Simon Daenen

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Jan J. Cornelissen, Wim L.J. van Putten, Leo F. Verdonck et al. · Blood · 2007 · 470 citations · Full text

Medicine, Hematology, Oncology +17

Effect of Priming with Granulocyte Colony-Stimulating Factor on the Outcome of Chemotherapy for Acute Myeloid Leukemia

Bob Löwenberg, Wim van Putten, Matthias Theobald et al. · New England Journal of Medicine · 2003 · 384 citations · Full text

Medicine, Hematology, Oncology +16

Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections

Alexander C. A. P. Leenders, Simon Daenen, Rob L. H. Jansen et al. · British Journal of Haematology · 1998 · 321 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.

Bob Löwenberg, M. Boogaerts, Simon Daenen et al. · Journal of Clinical Oncology · 1997 · 128 citations

Medicine, Hematology, Oncology +14

Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients

J Laaban, Simon Daenen, Damien Léger et al. · Diabetes & Metabolism · 2009 · 111 citations

Medicine, Endocrinology, Internal Medicine +16